Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | adenosine A2b receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Adenosine A1 receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0024 | 0.144 | 0.144 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0033 | 0.2521 | 0.2521 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0035 | 0.2799 | 0.6934 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0044 | 0.3879 | 0.3879 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.003 | 0.2134 | 0.2134 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0033 | 0.2521 | 0.2521 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0044 | 0.3879 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0044 | 0.3879 | 0.3653 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0044 | 0.3879 | 1 |
Echinococcus granulosus | 3-phosphoinositide-dependent protein kinase 1 | 0.0095 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0033 | 0.2521 | 0.2521 |
Trichomonas vaginalis | AGC family protein kinase | 0.0095 | 1 | 1 |
Leishmania major | target of rapamycin kinase (TOR) kinase 3 | 0.0035 | 0.2799 | 0.6934 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0044 | 0.3879 | 1 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0044 | 0.3879 | 0.3653 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0044 | 0.3879 | 0.3879 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0033 | 0.2521 | 0.2521 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0015 | 0.0355 | 0.0355 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0024 | 0.1436 | 0.1436 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0024 | 0.144 | 0.144 |
Leishmania major | target of rapamycin (TOR) kinase 1, putative | 0.0044 | 0.3879 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.2794 | 0.2794 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0024 | 0.1436 | 0.1436 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0026 | 0.1745 | 0.1745 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0038 | 0.3104 | 0.3104 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0026 | 0.1745 | 0.1745 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0095 | 1 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0044 | 0.3879 | 0.3653 |
Trypanosoma brucei | phosphatidylinositol 3-kinase tor, putative | 0.0021 | 0.1085 | 0.207 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0044 | 0.3879 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0095 | 1 | 1 |
Giardia lamblia | GTOR | 0.0044 | 0.3879 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0024 | 0.144 | 0.144 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0015 | 0.0355 | 0.0355 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0015 | 0.0355 | 0.0355 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0018 | 0.078 | 0.1204 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0024 | 0.1436 | 0.1436 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0026 | 0.1714 | 0.1714 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0024 | 0.144 | 0.144 |
Entamoeba histolytica | protein kinase, putative | 0.0095 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0033 | 0.2521 | 0.2521 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0033 | 0.2521 | 0.2521 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0044 | 0.3879 | 0.3653 |
Echinococcus multilocularis | 3 phosphoinositide dependent protein kinase 1 | 0.0095 | 1 | 1 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0033 | 0.2521 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0026 | 0.1745 | 0.1745 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.2794 | 0.2794 |
Leishmania major | target of rapamycin (TOR) kinase 2, putative | 0.0044 | 0.3879 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0095 | 1 | 1 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0044 | 0.3879 | 0.3653 |
Loa Loa (eye worm) | AGC/PDK1 protein kinase | 0.0095 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0044 | 0.3879 | 0.3879 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0015 | 0.0355 | 0.0355 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0033 | 0.2521 | 0.2521 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.2794 | 0.2794 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.2794 | 0.2794 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0035 | 0.2799 | 0.6934 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0015 | 0.0355 | 0.0355 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0029 | 0.2019 | 0.2019 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.2794 | 0.2794 |
Loa Loa (eye worm) | AGC/PDK1 protein kinase | 0.0095 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0026 | 0.1714 | 0.1714 |
Brugia malayi | Protein kinase domain containing protein | 0.0095 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 14 % | Percent inhibition of [3H]-PSB-11 binding to human Adenosine A3 receptor at 10 uM | ChEMBL. | 11906291 |
Inhibition (binding) | = 14 % | Percent inhibition of [3H]-PSB-11 binding to human Adenosine A3 receptor at 10 uM | ChEMBL. | 11906291 |
Inhibition (binding) | = 35 % | Inhibition of [3H]-CCPA binding against human Adenosine A1 receptor | ChEMBL. | 11906291 |
Inhibition (binding) | = 35 % | Inhibition of [3H]-CCPA binding against human Adenosine A1 receptor | ChEMBL. | 11906291 |
Ki (binding) | = 53.4 nM | Inhibition of [3H]-ZM-241,385 binding to human adenosine A2B receptor | ChEMBL. | 11906291 |
Ki (binding) | = 53.4 nM | Inhibition of [3H]-ZM-241,385 binding to human adenosine A2B receptor | ChEMBL. | 11906291 |
Ki (binding) | = 2200 nM | Inhibition of [3H]-CCPA binding to rat adenosine A1 receptor | ChEMBL. | 11906291 |
Ki (binding) | = 2200 nM | Inhibition of [3H]-CCPA binding to rat adenosine A1 receptor | ChEMBL. | 11906291 |
Ki (binding) | = 24000 nM | Inhibition of [3H]-MSX-2 binding to rat adenosine A2A receptor | ChEMBL. | 11906291 |
Ki (binding) | = 24000 nM | Inhibition of [3H]-MSX-2 binding to rat adenosine A2A receptor | ChEMBL. | 11906291 |
Ratio (binding) | = 453 | Selectivity ratio of the compound( A2A/A2B) | ChEMBL. | 11906291 |
Ratio (binding) | = 41 | Selectivity ratio of the compound (A1/A2B) | ChEMBL. | 11906291 |
Ratio (binding) | > 180 | Selectivity ratio (A3/A2B). | ChEMBL. | 11906291 |
Ratio (binding) | = 453 | Selectivity ratio of the compound( A2A/A2B) | ChEMBL. | 11906291 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.